• Lipoprotein(a) and Benefit of PCSK9 inhibition in patients with nominally controlled LDL cholesterolSchwartz, Gregory G.; Szarek, Michael; Bittner, Vera A.; Diaz, Rafael; Goodman, Shaun G.; Viigimaa, MargusJournal of the American College of Cardiology2021 / p. 421–433 : ill https://www.jacc.org/doi/epdf/10.1016/j.jacc.2021.04.102 https://doi.org/10.1016/j.jacc.2021.04.102